News

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types--the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles--that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.

A researcher has combined two decades of scientific studies on climate change in order to pinpoint the obstacles to behavior change and find ways to overcome them.

Scientists have revolutionized knowledge of the mitochondria organelle by revealing that whole functioning extracellular mitochondria are in fact found in the bloodstream.

Well-controlled study of more than 400 participants supports reducing salt intake as an important public health strategy to decrease incidence of hypertension, and debunks the notion that it contributes to weight gain.

Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines.

The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family of coronaviruses (CoVs) has jumped from animals to humans and sparked an outbreak. We look back at two earlier novel CoV outbreaks that initially caused global havoc and describe steps needed to contain the current one.

Understanding the process of liver fibrosis, could help researchers develop new ways to prevent or treat conditions such as alcoholic liver disease. A team has now demonstrated for the first time that liver fibrosis progression could potentially be targeted by manipulating a special population of liver cells.

A team has analyzed the role of immune cells in the expansion of glioblastoma, a type of aggressive brain tumor.

A team has discovered that a novel drug, called “FerriIridium”, is capable of simultaneously diagnosing and treating gastric cancer.

New insights into how the cancer-causing stomach bacterium keeps its shape could pave the way for the creation of more-specialized antibiotics.